PPARGC1A and chronic kidney disease: Several previous studies have demonstrated that CPT-I, acyl-CoA dehydrogenase, PPAR-α, and PGC-1α play important roles in limiting acute kidney injury (AKI) and chronic kidney disease (CKD) [6].